EUVIMEDEUVIMED entdecken
Leserbrief

Helicobacter pylori resistance in Australia: a call for active surveillance

Ravin Hettiarachchi iD, Raed Simhairi, Juliette Holland

Internal Medicine Journal · 2024

DOI: 10.1111/imj.16331 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Ravin Hettiarachchi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Laverty Pathology, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter pyloriHelicobacter InfectionsHumansWatchful WaitingAnti-Bacterial AgentsAustraliaClarithromycinDrug Resistance, BacterialMicrobial Sensitivity TestsMetronidazole

Substanzen

Anti-Bacterial AgentsClarithromycinMetronidazole

Autor:innen und Institutionen

  • Department of Microbiology, Laverty Pathology, Sydney, New South Wales, Australia.
  • St George and Sutherland Clinical School, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

ORCID-Profile: Ravin Hettiarachchi

Zitieren

APA

Hettiarachchi, R., Simhairi, R., & Holland, J. (2024). Helicobacter pylori resistance in Australia: a call for active surveillance. Internal Medicine Journal. https://doi.org/10.1111/imj.16331

Vancouver

Hettiarachchi R, Simhairi R, Holland J. Helicobacter pylori resistance in Australia: a call for active surveillance. Internal Medicine Journal. 2024. doi:10.1111/imj.16331

BibTeX
@article{Hettiarachchi2024,
  author = {Hettiarachchi, Ravin and Simhairi, Raed and Holland, Juliette},
  title = {Helicobacter pylori resistance in Australia: a call for active surveillance},
  journal = {Internal Medicine Journal},
  year = {2024},
  doi = {10.1111/imj.16331}
}
Kostenlos starten →